PharmaSGP Holding SE

  • WKN: A2P4LJ
  • ISIN: DE000A2P4LJ5
  • Land: Deutschland

Nachricht vom 27.04.2022 | 14:47

DGAP-DD: PharmaSGP Holding SE english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
27.04.2022 / 14:47
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Name and legal form: FUTRUE GmbH

2. Reason for the notification

a) Position / status
Person closely associated with:
Title: Dr.
First name: Clemens
Last name(s): Fischer
Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
PharmaSGP Holding SE

b) LEI
3912005CZ12PVVCIPT91 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A2P4LJ5

b) Nature of the transaction
Purchase order for up to 10,000 shares of PharmaSGP Holding SE at market-preserving conditions in the period from 25 April 2022 to 28 May 2022 at the latest at a maximum purchase price of EUR 28.00 per share; settlement order can be terminated with 2 stock exchange trading days' notice.

c) Price(s) and volume(s)
Price(s) Volume(s)
not numberable not numberable

d) Aggregated information
Price Aggregated volume
not numberable not numberable

e) Date of the transaction
2022-04-22; UTC+2

f) Place of the transaction
Outside a trading venue



27.04.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Events im Fokus

Termine 2022

1./2. Juni 2022: Fachkonferenz Immobilien & Software | IT

13./14. Juli 2022: Fachkonferenz Beteiligungsgesellschaften & Consumer/Leisure

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

News im Fokus

Siemens Aktiengesellschaft: Siemens kündigt außerplanmäßige Abschreibung auf at‐equity Beteiligung an

30. Juni 2022, 19:03

Aktueller Webcast

Kinarus Therapeutics Holding AG

Replay KOL Webcast: Christian Pruente on wAMD and KIN001

27. Juni 2022

Aktuelle Research-Studie

FORTEC Elektronik Aktiengesellschaft

Original-Research: FORTEC Elektronik AG (von Montega AG): Kaufen

01. Juli 2022